Jio Platforms' post-IPO playbook: What's ahead for No. 2 of Dalal Street?Reliance Jio Platforms made a blockbuster stock market debut, listing at a 21.4% premium and reaching a $131.5 billion valuation. After Ind...
28 Oct, 2026, 05.34 PM IST
QClairvoyance's quantum chemistry bet: Transitioning from research to pharma partnershipsQClairvoyance Quantum Labs has performed chemically precise simulations of eight small molecules on an actual quantum computer, marking pro...
28 Oct, 2026, 11.46 AM IST
Sahajanand Medical Technologies shares list at 8% premium over IPO price on NSEThe Rs 475.48 crore IPO comprised an offer for sale (OFS) of 1.38 crore shares. Since the issue was entirely an OFS, the company will not r...
23 Oct, 2026, 10.02 AM IST
Jio IPO closes today: Will it deliver a double-digit listing gain or become a long-term compounder?Jio Platforms will wrap up its IPO bidding today, setting a new benchmark as India's largest public offering to date. With an overwhelming ...
23 Oct, 2026, 09.22 AM IST
HPCL Q2 Results: Profit slips 6% YoY to Rs 3,625 crore, revenue jumps 26%HPCL reported Q2FY27 net profit of Rs 3,625 crore, recovering from a previous-quarter loss. Revenue rose 26.1% year-on-year, refining margi...
22 Oct, 2026, 05.54 PM IST
Jio IPO Day 2: Issue subscribed over 5X; GMP at 22%. Check brokerage views and key detailsJio Platforms' Rs 30,213 crore IPO was subscribed 5.23 times by the end of Day 2, led by strong institutional demand, while the retail port...
22 Oct, 2026, 05.25 PM IST
Jio IPO Day 1: Issue subscribed 3 times on strong QIB push; retail portion booked 68%. Check GMPJio Platforms’ IPO saw strong demand on Day 1, getting booked 3 times overall. The IPO commanded a grey market premium (GMP) of around 23%,...
21 Oct, 2026, 05.21 PM IST
From Dhirubhai to Akash Ambani, Reliance made stocks popular with IndiansJio Platforms’ IPO is putting the Ambani family’s relationship with India’s retail investors on a new footing, almost five decades after Dh...
21 Oct, 2026, 04.27 PM IST
Jio IPO: Nithin Kamath explains how Jio played an important role in making what Zerodha is todayZerodha CEO Nithin Kamath has credited Reliance Jio and Airtel with helping build India’s digital ecosystem and expand capital markets. Ref...
21 Oct, 2026, 01.35 PM IST
Jio IPO beyond telecom: Why the Ambanis are pitching AI, cloud and 7,220 patents as Jio’s tech futureJio Platforms ₹30,213 crore IPO marks a significant shift toward technology-driven digital services. With a focus on leveraging its connect...
21 Oct, 2026, 09.24 AM IST
Jio IPO opens with 22% GMP: Check brokerage views, allotment chances and other detailsThe Rs 30,213 crore IPO, priced between Rs 1,065 and Rs 1,119 per share, will remain open until October 23. At the upper end of the price b...
21 Oct, 2026, 07.55 AM IST
Jio Platforms IPO GMP signals 22% potential listing gain; issue opens on October 21Jio Platforms’ Rs 30,213-crore IPO will open for subscription on October 21 and close on October 23, 2026. The issue comprises a fresh issu...
19 Oct, 2026, 11.45 AM IST
Sahajanand Medical Technologies IPO Day 3: GMP at 7%; check subscription status and key detailsSahajanand Medical Technologies’ IPO enters its final bidding day with 82% subscription on Day 2 and a 7% grey market premium. The Rs 475.4...
19 Oct, 2026, 09.41 AM IST
Jio Platforms joins global top 20 patent filers as Reliance readies first IPO in 30 yearsJio Platforms has achieved a significant milestone by entering the global top 20 patent filers as of March 2026. The company has filed over...
18 Oct, 2026, 12.06 PM IST
AYUSH sees rise in patents filings showcasing innovation growth; 4,077 applications filed from 2014 to 2026Ayush-related Intellectual Property activity has seen substantial growth, with over 4,000 patent applications from 2014 to 2026. The Minist...
16 Oct, 2026, 06.17 PM IST
Reliance Jio IPO: With tech muscle, Akash Ambani makes $1.4 trillion digital economy pitch to investorsAkash Ambani is positioning Jio Platforms to capture a significant share of India’s projected $1.4 trillion digital economy by FY31. Ahead ...
15 Oct, 2026, 06.03 PM IST
Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
14 Oct, 2026, 12.32 AM IST